Goldline Pharmaceutical share news and announcements
BSE: 544759Pharmaceuticals & BiotechnologySmall Cap
Last close ₹30.10up ₹0.12 (0.40%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.98.
Range of traded prices from listing on 19 May 2026 to 23 Oct 2026
₹28.13Low, 21 Oct 2026₹60.00High, 19 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,537th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 9 Jun 2026
- 7.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 9 Jun 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 9 Jun 2026
- 28.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 Jun 2026
- 0.64
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,000
Goldline Pharmaceutical routine notices
6 filed, newest first.
Oct 2026
Sep 2026
24 Sep · Routine
Aug 2026
Jul 2026
20 Jul · Routine
Jun 2026
May 2026
27 May · Routine